又一种单克隆抗体获欧盟批准用于治疗 COVID-19。

Another Monoclonal Antibody Granted EUA to treat COVID-19.

机构信息

Diane S. Aschenbrenner is a COVID-19 outbreak investigator for the Baltimore County Department of Health, Baltimore, MD. She also coordinates Drug Watch :

出版信息

Am J Nurs. 2021 Aug 1;121(8):22. doi: 10.1097/01.NAJ.0000767788.97481.65.

DOI:10.1097/01.NAJ.0000767788.97481.65

PMID:34819468

Abstract

The Food and Drug Administration has granted emergency use authorization to sotrovimab for the treatment of mild to moderate COVID-19 in patients at increased risk for progression to severe illness.Sotrovimab is a monoclonal antibody that works directly against the spike protein of SARS-CoV-2 to block its attachment and entry into a human cell.

摘要

美国食品和药物管理局已批准 sotrovimab 用于治疗有进展为重症风险的 COVID-19 轻症和中度患者。Sotrovimab 是一种单克隆抗体，可直接针对 SARS-CoV-2 的刺突蛋白发挥作用，阻止其附着和进入人体细胞。